approach to anemia abdul-kareem al-momen, md, frcpc ksu-med 341 17-04-2011 (13-05-1432)

63
Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Upload: annabella-hardy

Post on 15-Jan-2016

218 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Approach to anemia

• Abdul-Kareem Al-Momen, MD, FRCPC• KSU-MED 341

• 17-04-2011 (13-05-1432)

Page 2: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Anemia is defined as a reduction in one or more of the major RBC measurements:hemoglobin concentration, hematocrit, or RBC count to a degree lower than normal values for the tested population :newborn, childhood, adulthood (males & females), and sea level

Definition:

Page 3: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

NewbornNewborn

ChldChld..

AdultAdult::

MaleMale

FemaleFemale

Sea LevelSea Level : :

JeddahJeddah

Hi.Alt.:AlbahaHi.Alt.:Albaha

Hb (gm/L)Hb (gm/L)

200200 -/+ -/+ 2020

110110 -/+ -/+ 1010

160160 -/+ -/+ 2020

1414 -/+ -/+ 2020

150150 g/Lg/L

190190 G/lG/l

PCV (Hct)PCV (Hct)%%

6060 -/+ -/+ 2020

3333 -/+ -/+ 33

4848 -/+ -/+ 55

4242 -/+ -/+ 55

4747% %

5858% %

Page 4: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Anemia?

Production? Destruction?

The key test is the reticulocytic count

Page 5: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

The reticulocyte count

• Increased reticulocytes (greater than 2-3% or 100,000/mm3 total) are seen in blood loss and hemolytic processes.

Page 6: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

The reticulocyte count• To be useful the reticulocyte count must be adjusted for

the patient's hematocrit, because when hematocrit is low, reticulocytes are released earlier (faster) from the marrow so one can adjust for this phenomenon as follows:

• Corrected retic. = Patients retic. x (Patients Hct/45)

Example: Hb 70 g/L, PCV (Hct) = 20, Retics.= 16 %Corrected Retics.= 16 X 20/45 = 7

Page 7: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

The reticulocyte count • Reticulocyte Production index (RPI) = corrected retic.

count/Maturation time (Maturation time = 1 for Hct=45%, 1.5 for 35%, 2 for

25%, and 2.5 for 15%.)Example: PCV = 20 %, Retics.= 16, Corrected Retics=7RPI = 7/2 = 3.5

• Absolute reticulocyte count = retic x RBC number.

Page 8: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)
Page 9: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)
Page 10: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)
Page 11: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)
Page 12: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)
Page 13: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Causes of Anemia (kinetic approach)

Decreased erythrocyte production

Bone marrow suppression

Bone marrow infiltration

Nutritional deficiencies

Decreased erythropoietin production

Inadequate marrow response to erythropoietin

Page 14: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Causes of Anemia Blood loss

•Hemorrhage :

Bleeding tendencies,

Menorrhagea,

Anticoagulation

Liver disease

Hemolysis:

Autoimmune,

None-immune, (MAHA,

RBC defects, Hypersplenism)

Page 15: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Dilutional Anemia

• Dilutional- A patient's plasma volume increases with pregnancy,(Splenomegally), laying down possibly responsible for as much as a 3-6% drop in the hematocrit in the first two days of hospitalization.

Page 16: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

First, measure the size of the RBCs:First, measure the size of the RBCs:

   MCV  (femtoliters) = 10 x HCT(percent) ÷ RBC (millions/µL)

Morphological Approach(big versus small)

Page 17: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

High MCV

MCV>115• B12, Folate• Drugs that impair DNA synthesis (AZT,

chemo., azathioprine)• MDS

Page 18: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Normal MCV

Normocytic normocytic• Anemia of chronic disease• Mixed deficiencies• Renal failure• Endocrinopaties

Page 19: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Low MCV

Microcytic• Iron deficiency• Thalassemia trait• Anemia of chronic disease (30-40%)• Sideroblastic anemias• Lead poisoning

Page 20: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Iron deficiency anemia

• Iron deficiency is a common form of malnutrition that affects more than 2 billion people globally.

Page 21: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Iron Deficiency Anemia

– Smear:• hypochromic and microcytic (low MCV) RBCs,

usually not seen unless Hct 30%• platelet count is often elevated

– Ferritin: a measure of total body iron stores, but also an acute phase reactant

• <15g/l = Fe deficiency, 150 g/l = Not Fe deficiency 15-150 g/l = ?

Page 22: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)
Page 23: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)
Page 24: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)
Page 25: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)
Page 26: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Iron Deficiency Anemia

– Low Iron Saturation (Fe/TIBC ratio)• Fe (not reliable)• TIBC • Fe/TIBC (% saturation) 15%

– BM bx: absent Fe stores• Gold standard

– Therapeutic Trial of Oral Iron

Page 27: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Increased iron requirements

•Blood loss

•Gastrointestinal disorders (esophageal varices, hemorrhoids)

•Extensive and prolonged menstruation

•Pulmonary (hemoptysis, pulmonary hemosiderosis), urologic, or nasal disorders

•Dialysis

•Hookworm infestation

•Intravascular hemolysis with hemoglobinuria

•Paroxysmal nocturnal hemoglobinuria

•Cardiac valve prostheses

•Rapid growth in body size between 2 and 36 months of age

•Pregnancy and lactation

Page 28: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Inadequate iron supply

• Poor nutritional intake in children (not a common independent mechanism in adults but often a contributing factor)

• Malabsorption

• Gastric bypass surgery for ulcers or obesity

• Achlorhydria from gastritis or drug therapy

• Severe malabsorption (for example, celiac disease [nontropical sprue])

• Abnormal transferrin function

• Congenital atransferrinemia

• Autoantibodies to transferrin receptors

Page 29: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Oral iron failure?

• Incorrect diagnosis (eg, thalassemia)

• anemia of chronic disease?

• Patient is not taking the medication

• Not absorbed (enteric coated?)

• Rapid iron loss?

Page 30: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Intravenous Iron Therapy• Iron sacharate (Ferrosac), 200 mg in 100-250 cc normal saline IV over one hour daily to the total dose required•(Weight {kg} x Hb deficit {target Hb-current Hb] x 4).

• Ferric gluconate (Ferrlecit ) in patients on renal dialysis. The number of allergic reactions is lower than that from iron dextran

Page 31: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)
Page 32: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Utility of supraphysiologic doses of erythropoietinerythropoietin in the setting of inflammatory block.

Page 33: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

B12/Folate Deficiency• Etiology:

– Anemia-- Vitamin B12 and folate are needed for DNA synthesis deoxyuridate to thymidylate , including RBC precursors

– Deficiency• B12 - Dietary intake, acid-pepsin in the

stomach, pancreatic proteases, gastric secretion of intrinsic factor, an ileum with Cbl-IF receptors (fish tapeworm)

• Folate-- Poor dietary intake EtOH, malabsorption, increased demand (pregnancy, hemolytic anemias), inhibitors of DHFR

Page 34: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

B12/Folate Deficiency (2)

• Dx:– Smear: Macrocytic (High MCV) RBCs, +/- hypersegmented

neutrophils, +/- modest neutropenia, but…– the diagnosis of B12 def. was made in patients in whom only

29 percent had anemia, and only 36 percent had a MCV greater than 100 fL (Pruthi RK, Tefferi A, Mayo Clin Proc 1994 Feb;69(2):144-50)

– B12• Low serum B12, elevated serum methylmalonic acid

levels• Anti-IF Abs, Schilling test (?), PA accounts for 75%

– Folate• Serum folate level-- can normalize with a single good

meal

Page 35: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

B12/Folate Deficiency (3)

• Tx:– B12 deficiency: B12 1 mg/month IM, or 1-2

mg/day po

– Folate deficiency: Improved diet, folate 1 mg/day

– Monitor for a response to therapy.

– Pernicious Anemia – monitor for gi cancers.

Page 36: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Cobalamin deficiency and neurological problems

• Subacute combined degeneration of the dorsal and lateral spinal columns.

• Well known study of B12 deficiency in the nursing home population (Carmel R Karnaze DS, JAMA 253:1284, 1985)

• Vitamin B-12 deficiency is present in up to 15% of the elderly population as documented by elevated methylmalonic acid in combination with low or low-normal vitamin B-12 concentrations.

• Is oral B12 good enough?

• Association between nitrous oxide anesthesia and development of neurological symptoms responsive to B12 in

patients with subclinical cobalamin deficiency (methionine?).

Page 37: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Diagnostic tests for Vit. B12 Deficiency

TestTest

Serum methylmalonic acid and Serum methylmalonic acid and serum homocysteineserum homocysteine

MCV>115, smear, CBCMCV>115, smear, CBC

Antibodies to IF and Parietal cellsAntibodies to IF and Parietal cells

Schilling testSchilling test

Spot urine for homocysteineSpot urine for homocysteine

Page 38: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Sideroblastic Anemias

• Heterogenous grouping of anemias defined by presence of ringed sideroblasts in the BM

• Etiologies:– Hereditary (rare), type of porphyria– Myelodysplasia– EtOH– Drugs (INH, Chloramphenicol)

• Tx:– Trial of pyridoxine for hereditary or INH induced

SA

Page 39: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)
Page 40: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Hemolytic AnemiasHemolytic Anemias

Hemolytic anemias are either acquired or congenital. The laboratory signs of hemolytic anemias include:

1. Increased LDH (LDH1) - sensitive but not specific. 2. Increased indirect bilirubin - sensitive but not specific*. 3. Increased reticulocyte count - specific but not sensitive 4. Decreased haptoglobin - specific but not sensitive. 5. Urine hemosiderin - specific but not sensitive.

*The indirect bilirubin is proportional to the hematocrit, so with a hematocrit of 45% the upper limit of normal is 1.00 mg/dl and with a hematocrit of 22.5% the upper limit of normal for the indirect bilirubin is 0.5mg/dl. Since tests for hemolysis suffer from a lack of sensitivity and specificity, one needs a high index of suspicion for this type of anemia.

Page 41: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)
Page 42: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Hereditary anemias• 1- RBC memberane defects :e.g.Heriditary

Spherocytosis• 2-Reduced Globin Chains:e.g. α

thalassemia ( reduced α chain ) ,& β thalassemia ( reduced β chain)

• 3-Abnormal amino-acid sequence e.g. Sickle Cell Anemia

• 3-Enzymopathies :e.g G6PD deficiency

Page 43: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Hemoglobinopathies

• Sickle cell disease/anemia• Thalassemias

Page 44: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Sickle Cell Anemia / Disease

• Hb SS due to replacement of glutamic acid by valine at position 6 on the β globin chain

• HbS molecule are less soluble ,tend to form crystals and fibers,which leads to RBC deformity ,sickling ,vaso-occlusion & hemolysis

Page 45: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)
Page 46: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)
Page 47: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Complications of Sickle Cell Disease

• 1- Vaso-occlusion ,with recurrent painful episodes (mild-moderate-severe )

• Acute chest syndrome• Recurrent infection (URT & chest )• Splenic sequestration• Priapism• Thrombo-embolic disease (CVA,PE,DVT)

Page 48: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

SCD Complication: (cont.)

• Avascular necrosis (head of femur & humerus)• Tendency for Osteo-myelitis ( salmonella)• Leg ulcers• Gall stones

Page 49: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Presipitators of Vaso-Occlusive Episodes

• 1-Hypoxia : - low atmospheric oxygen , Lung diseases ,heart diseases

• 2-Increased blood viscosity: increased Hb/Hct ,dehydration, infection ,general anesthesia

• 3-Extreme hot/cold weather• 4-Unknown causes

Page 50: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Management of SCD

• Vaccination• Antibiotic prophylaxis• Avoidance of hypoxia and extreme weathers• Increase fluid intake• Treatment of acute episodes• Exchange transfusion /transfusion• Prevention: premarital screening & genetic

counseling

Page 51: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

β Thalassemia

• 2 β genes on chromosome # 11 give 2 β globin chains.

• ββ = normal• -β = β thalassemia trait (hypochromic ,

microcytic anemia, asymptomatic , confused with iron deficiency anemia )

Page 52: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Thalassemia Major (Homozygous β Thalassemia )• No β chains• Severe intramedullary hemolysis• Severe hemolytic anemia• Jaundice + Pallor• Bone marrow expansion• Hepatosplenomegaly• Delayed puperty• Iron overload ( absorption + hemolysis )

Page 53: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)
Page 54: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)
Page 55: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)
Page 56: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

H. Spherocytosis

• RBC = Spheres (not biconcave )_• Reduced survival (hemolytic anemia )• Jaundice,• Splenomegaly• Gall stones• Reticulocytosis• Increased direct billirubin

Page 57: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Treatment

• 1-Folic acid• 2-Splenectomy after vaccination against

S.Pneomoniae & H.Influenzaeز• Malaria avoidance / prophylaxis

Page 58: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Enzymopathies : G6PD Deficiency

• G6PD is essential for the production of the anti-oxidant Glutathione

• Acute hemolysis upon exposure to oxidative stress food (fava beans),drugs (e.g.sulfa derivatives ),chemicals or infection

• X- linked

Page 59: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)
Page 60: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Approach to anemia:

• History: Onset (acute versus chronic),Age at onset, character, associations (splenomegally, growth retardation, painful episodes, transfusions, dietary habits, family history, consanguinity, involvement of other systems, drug history : ASA, anticoagulantsetc )

• Symptoms (fatigue, exercise intolerance, headache, palpitation, lack of concentration, poor appetite,

• Adaptation

Page 61: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Approach to anemia:

• Signs (physical exam): Pallor, dry skin, smooth tongue, thin hair, hair loss, splenomegally, neuropathy,

• Signs of systemic diseases ( renal, hepatic, musculoskeletal, cancer, infection, etc )

Page 62: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

Approach to anemia:

• Laboratory: RBC, Hb, Hct (PCV), MCV, MCH, MCHC, RDW, Reticulocytes, WBC, Platelets, blood filnm ( smear)

• Fe, Transferrin, ferritin, B12, folates (RBC)• ESR, ANA, RF, BUN, Cr, • Hb electrophoresis (Hb A, A2, S, F, )

Page 63: Approach to anemia Abdul-Kareem Al-Momen, MD, FRCPC KSU-MED 341 17-04-2011 (13-05-1432)

•Good Luck